MXPA02007954A - Agente farmacologico que comprende acido-picolinico, acido furasico y sus derivados. - Google Patents
Agente farmacologico que comprende acido-picolinico, acido furasico y sus derivados.Info
- Publication number
- MXPA02007954A MXPA02007954A MXPA02007954A MXPA02007954A MXPA02007954A MX PA02007954 A MXPA02007954 A MX PA02007954A MX PA02007954 A MXPA02007954 A MX PA02007954A MX PA02007954 A MXPA02007954 A MX PA02007954A MX PA02007954 A MXPA02007954 A MX PA02007954A
- Authority
- MX
- Mexico
- Prior art keywords
- derivatives
- acid
- antiinflammatory
- preparations
- metals
- Prior art date
Links
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 title abstract 4
- 229940081066 picolinic acid Drugs 0.000 title abstract 2
- DGMPVYSXXIOGJY-UHFFFAOYSA-N Fusaric acid Chemical compound CCCCC1=CC=C(C(O)=O)N=C1 DGMPVYSXXIOGJY-UHFFFAOYSA-N 0.000 title 2
- 239000002831 pharmacologic agent Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 239000002184 metal Substances 0.000 abstract 3
- 229910052751 metal Inorganic materials 0.000 abstract 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- 230000001028 anti-proliverative effect Effects 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000028709 inflammatory response Effects 0.000 abstract 2
- 150000002739 metals Chemical class 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010059313 Anogenital warts Diseases 0.000 abstract 1
- 208000000907 Condylomata Acuminata Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 208000001688 Herpes Genitalis Diseases 0.000 abstract 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- 102000007474 Multiprotein Complexes Human genes 0.000 abstract 1
- 108010085220 Multiprotein Complexes Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 208000019802 Sexually transmitted disease Diseases 0.000 abstract 1
- 206010042496 Sunburn Diseases 0.000 abstract 1
- 208000000260 Warts Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 208000025009 anogenital human papillomavirus infection Diseases 0.000 abstract 1
- 201000004201 anogenital venereal wart Diseases 0.000 abstract 1
- 230000001772 anti-angiogenic effect Effects 0.000 abstract 1
- 230000002924 anti-infective effect Effects 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000013522 chelant Substances 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 201000004946 genital herpes Diseases 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 201000010153 skin papilloma Diseases 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/04—Chelating agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18260800P | 2000-02-15 | 2000-02-15 | |
| PCT/US2001/004897 WO2001060349A2 (en) | 2000-02-15 | 2001-02-15 | Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02007954A true MXPA02007954A (es) | 2004-09-10 |
Family
ID=22669217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02007954A MXPA02007954A (es) | 2000-02-15 | 2001-02-15 | Agente farmacologico que comprende acido-picolinico, acido furasico y sus derivados. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6403618B1 (enExample) |
| EP (1) | EP1257262A2 (enExample) |
| JP (1) | JP2003522786A (enExample) |
| AU (1) | AU781066B2 (enExample) |
| BR (1) | BR0108400A (enExample) |
| DE (1) | DE01909253T1 (enExample) |
| ES (1) | ES2215493T1 (enExample) |
| MX (1) | MXPA02007954A (enExample) |
| TR (1) | TR200301378T3 (enExample) |
| WO (1) | WO2001060349A2 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6579891B1 (en) * | 1995-12-29 | 2003-06-17 | Novactyl, Inc. | Agent and method for prevention and treatment of cancer in animals |
| US20060074063A1 (en) * | 1995-12-29 | 2006-04-06 | Fernandez-Pol Jose A | Pharmacological agent and method of treatment |
| WO2003018014A2 (en) * | 2001-08-23 | 2003-03-06 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods of inhibiting formation of vascular channels and profileration using pyridinone derivatives |
| WO2003055477A1 (en) * | 2001-12-21 | 2003-07-10 | 7Tm Pharma A/S | Method for the treatment of mc receptor related disorders with a chelate and/or a chelator |
| CN101134119A (zh) * | 2002-05-24 | 2008-03-05 | 血管技术国际股份公司 | 用于涂覆医用植入物的组合物和方法 |
| US8313760B2 (en) | 2002-05-24 | 2012-11-20 | Angiotech International Ag | Compositions and methods for coating medical implants |
| CA2536242A1 (en) * | 2003-11-20 | 2005-06-09 | Angiotech International Ag | Implantable sensors and implantable pumps and anti-scarring agents |
| EP1732500B1 (en) * | 2004-01-07 | 2018-11-21 | E-L Management Corporation | Cosmetic composition and method for retarding hair growth |
| US20050239723A1 (en) * | 2004-04-27 | 2005-10-27 | Amin Avinash N | Compositions and methods useful for treatment of acne |
| US20070178062A1 (en) * | 2005-10-07 | 2007-08-02 | Nathan Ravi | Treatment of presbyopia with picolinic acid and its analogs |
| AU2006304860A1 (en) * | 2005-10-20 | 2007-04-26 | Viamet Pharmaceuticals, Inc. | Screening for modulators of metalation pathways for metalloproteins |
| US20120321573A1 (en) | 2009-10-02 | 2012-12-20 | The General Hospital Corporation | Compositions and methods of prophylaxis for contact dermatitis |
| GB201317619D0 (en) | 2013-10-04 | 2013-11-20 | Uni I Oslo | Compounds |
| ES2954072T3 (es) * | 2016-07-28 | 2023-11-20 | Jiangsu Yahong Meditech Co Ltd | Usos de inhibidores de la dopamina beta-hidroxilasa (DBH) para el tratamiento del cáncer |
| GB201613946D0 (en) | 2016-08-15 | 2016-09-28 | Univ Oslo | Compounds |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3903285A (en) | 1972-12-29 | 1975-09-02 | Microbial Chem Res Found | Method for treating parkinsonism |
| US4044140A (en) | 1975-11-28 | 1977-08-23 | Schering Corporation | Trityl picolinic acid derivatives and their use as anti-acne agents |
| ZA767103B (en) | 1975-11-28 | 1977-10-26 | Scherico Ltd | Picolinic acid derivatives and processes for their preparation |
| CH629488A5 (en) | 1975-11-28 | 1982-04-30 | Scherico Ltd | Processes for preparing novel picolinic acid derivatives. |
| US4120762A (en) | 1977-09-30 | 1978-10-17 | Alden Research Foundation | Electrochemical recording medium |
| US4293547A (en) | 1980-08-25 | 1981-10-06 | The Upjohn Company | Method of treating malaria |
| US4443459A (en) | 1981-05-26 | 1984-04-17 | Banyu Pharmaceutical Co., Ltd. | α-Tocopheryl ester of 5-substituted picolinic acid and hypotensive composition containing it |
| US4814351A (en) | 1987-06-26 | 1989-03-21 | Redken Laboratories, Inc. | Scalp treatment |
| US5536743A (en) | 1988-01-15 | 1996-07-16 | Curatek Pharmaceuticals Limited Partnership | Intravaginal treatment of vaginal infections with buffered metronidazole compositions |
| US5057320A (en) | 1988-08-01 | 1991-10-15 | Nutrition 21 | Means and method for increasing skin respiration |
| US5157046A (en) | 1988-11-29 | 1992-10-20 | Janssen Pharmaceutica N.V. | Method of treating epithelial disorders |
| US5219847A (en) | 1989-06-12 | 1993-06-15 | Shiseido Company, Ltd. | Antipruritic composition |
| FR2657259A1 (fr) | 1990-01-25 | 1991-07-26 | Adir | Utilisation de la n-myristoyl-(s)-phenylalanine pour l'obtention de medicaments destines au traitement des maladies faisant intervenir la myristoylation. |
| US5484951A (en) | 1990-10-19 | 1996-01-16 | Octamer, Incorporated | 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents |
| US5391537A (en) | 1990-10-25 | 1995-02-21 | Kumiai Chemical Industry Co., Ltd. | Picolinic acid derivative, and herbicidal composition |
| US5403816A (en) | 1990-10-25 | 1995-04-04 | Kumiai Chemical Industry Co., Ltd. | Picolinic acid derivative and herbicidal composition |
| US5173486A (en) | 1991-08-26 | 1992-12-22 | Bristol-Myers Squibb Company | Dibenz[b,f][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents |
| US5516941A (en) | 1991-10-22 | 1996-05-14 | Octamer, Inc. | Specific inactivators of "retroviral" (asymmetric) zinc fingers |
| IL104323A0 (en) | 1992-01-10 | 1993-05-13 | Smithkline Beecham Corp | Hemoregulatory peptides |
| US5284840A (en) | 1992-06-12 | 1994-02-08 | Merck & Co., Inc. | Alkylidene macrolides having immunosuppressive activity |
| US5962463A (en) * | 1992-10-09 | 1999-10-05 | Massachusetts Institute Of Technology | Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein |
| JPH09504266A (ja) | 1993-05-24 | 1997-04-28 | スミスクライン・ビーチャム・コーポレイション | 血液調節ペプチド |
| US6001555A (en) | 1994-09-23 | 1999-12-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| FR2736263B1 (fr) | 1995-07-07 | 1997-09-26 | C3D Sarl | Composition dermocosmetique depigmentante et son utilisation |
| US5767135A (en) | 1995-12-29 | 1998-06-16 | Fernandez-Pol; Jose Alberto | Antiviral agent |
| JP3337992B2 (ja) | 1997-11-04 | 2002-10-28 | ファイザー製薬株式会社 | ５−置換ピコリン酸化合物及びその製造方法 |
-
2000
- 2000-10-02 US US09/677,506 patent/US6403618B1/en not_active Expired - Fee Related
-
2001
- 2001-02-15 EP EP01909253A patent/EP1257262A2/en not_active Withdrawn
- 2001-02-15 WO PCT/US2001/004897 patent/WO2001060349A2/en not_active Ceased
- 2001-02-15 MX MXPA02007954A patent/MXPA02007954A/es unknown
- 2001-02-15 AU AU37028/01A patent/AU781066B2/en not_active Ceased
- 2001-02-15 TR TR2003/01378T patent/TR200301378T3/xx unknown
- 2001-02-15 JP JP2001559447A patent/JP2003522786A/ja active Pending
- 2001-02-15 ES ES01909253T patent/ES2215493T1/es active Pending
- 2001-02-15 BR BR0108400-3A patent/BR0108400A/pt not_active IP Right Cessation
- 2001-02-15 DE DE0001257262T patent/DE01909253T1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TR200301378T3 (tr) | 2003-12-22 |
| AU781066B2 (en) | 2005-05-05 |
| EP1257262A2 (en) | 2002-11-20 |
| ES2215493T1 (es) | 2004-10-16 |
| WO2001060349A3 (en) | 2001-11-08 |
| BR0108400A (pt) | 2003-03-11 |
| DE01909253T1 (de) | 2004-04-15 |
| WO2001060349A2 (en) | 2001-08-23 |
| US6403618B1 (en) | 2002-06-11 |
| AU3702801A (en) | 2001-08-27 |
| WO2001060349B1 (en) | 2001-12-27 |
| JP2003522786A (ja) | 2003-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002020486A3 (en) | Picolinic acid derivatives for the prevention and treatment of cancer in animals | |
| MXPA02007954A (es) | Agente farmacologico que comprende acido-picolinico, acido furasico y sus derivados. | |
| ATE310518T1 (de) | Antivirale verbindung | |
| Perkins et al. | Anti-viral activities of several iodinated pyrimidine deoxyribonucleosides | |
| WO2003022210A3 (en) | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith | |
| NZ337211A (en) | Method of treating inflammatory, HIV diseases by using peptidyl boronic acid ester and acid compounds as proteasome inhibitors | |
| YU64702A (sh) | Antiinfektivne kombinacije aktivnih supstanci i njihova primena za lokalno lečenje gljivičnih oboljenja noktiju na prstima nogu i ruku | |
| PL343360A1 (en) | Fatty acid derivatives of bile acids and bile acid derivatives | |
| WO1999066063A3 (en) | Nucleosidic and non-nucleosidic folate conjugates | |
| UA41879C2 (uk) | Засіб для лікування мотонейронових захворювань | |
| NO954440D0 (no) | 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler | |
| IL154693A (en) | Use of testosterone gel to make a remedy for testosterone deficiency in women | |
| MX9602973A (es) | Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida. | |
| PL376439A1 (en) | Multivalent metal salts of boronic acids for treating thrombosis | |
| Lv et al. | Discovery of novel non-sulfonylurea NLRP3 inflammasome inhibitors for the treatment of multiple inflammatory diseases | |
| TW200503720A (en) | Anti-tumor effect intensifier and antitumor agent | |
| IT1260155B (it) | Uso terapeutico della fosforil-l-serina-n-acil-sfingosina | |
| SE0200475D0 (sv) | Oral farmaceutisk beredning | |
| AU8447991A (en) | Antineoplastic effect potentiator and antineoplastic agent | |
| HUP0300601A3 (en) | Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability | |
| Zhou et al. | Orthogonal polynomial decomposition model for the flatness of cold-rolled strip | |
| Parr et al. | The design fundamentals of high technology castables-- an understanding for steelmakers | |
| Fei et al. | On the Progress of Roll Technology in the Light of the Variation of Roll Materials Used in Baoshan Iron and Steel Corporation | |
| Rupprecht et al. | Sequestering agents for lead (II): Synthesis and coordination chemistry of thiohydroxamic acids | |
| Joo | The role of anions in the active-state electrochemical metal dissolution process |